Washington, D.C. 20549
Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F:
Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(1):
☐
Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(7):
☐
Indicate by check mark whether the registrant by furnishing the information contained in this Form is also thereby furnishing the information to the Commission pursuant to Rule 12g3-2(b) under the Securities Exchange Act of 1934:
If “Yes” is marked, indicate below the file number assigned to the registrant in connection with Rule 12g3-2(b): n/a
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.
|
|
|
|
|
Semiconductor Manufacturing International Corporation
|
|
|
|
Date: September 29, 2017
|
By:
|
/s/ Dr. Gao Yonggang
|
|
|
Name:
|
Dr. Gao Yonggang
|
|
|
Title:
|
Executive Director, Chief Financial Officer and Joint Company Secretary
|
2
Hong Kong Exchanges and Clearing Limited and The Stock Exchange of Hong
Kong Limited take no responsibility for the contents of this announcement, make no representation as to its accuracy or completeness and expressly disclaim any liability whatsoever for any loss howsoever arising from or in reliance upon the whole or any p
art of the contents of this announcement.
SEMICONDUCTOR MANUFACTURING INTERNATIONAL CORPORATION
中芯國際集成電路製造有限公司*
(Incorporated in the Cayman Islands with limited liability)
(STOCK CODE: 981)
POLL RESULTS OF THE EXTRAORDINARY GENERAL MEETING
HELD ON 29 SEPTEMBER 2017
The Company is pleased to announce that all the resolutions proposed at the EGM held on 29 September 2017 were duly passed by the Shareholders by way of poll.
Reference is made to the Company’s circular dated 13 September 2017 (the “
Circular
”) in relation to, among other things, the following:
|
1.
|
the Amendment JV Agreement and the Capital Increase Agreement;
|
|
2.
|
the proposed grant of Restricted Share Units to former chief executive officer;
|
|
3.
|
the proposed grant of Restricted Share Units to chief executive officer and director; and
|
|
4.
|
notice of extraordinary general meeting
(the “
Notice
”)
.
|
Unless otherwise specified, capitalised terms used herein shall have the same meanings as defined in the Circular.
POLL RESULTS OF THE EGM
The Company is pleased to announce that at the EGM held on 29 September 2017, all the proposed resolutions set out in the Notice contained in the Circular were duly passed by the Shareholders by way of poll.
As at the date of the EGM, the total number of Shares in issue was 4,651,624,748 Shares.
The Shareholders and authorised proxies holding an aggregate of 2,425,750,763 Shares, representing 52.15% of the total Shares in issue were present at the commencement of the EGM:
3
(1) the total number of Shares e
ntitling the holders to attend and vote for or against the ordinary resolution numbered
1
was
3,911,624,748
Shares;
(2) the total number of Shares entitling the holders to attend and vote for or against the ordinary resolution numbered 2 was 4,647,105,387 Shares;
(3) the total number of Shares entitling the holders to attend and vote for or against the ordinary resolution numbered 3 was 4,651,575,437 Shares;
(4) the total number of Shares entitling the holders to attend and vote for or against the ordinary resolution numbered 4 was 4,647,105,387 Shares; and
(5) As at the date of the EGM, the number of Shares entitling the holders to attend and abstain from voting in favour as set out in Rule 13.40 of the Listing Rules at the EGM was nil.
As set out in the Circular and in accordance with the Listing Rules, as China IC Fund is a connected person of the Company, its wholly-owned subsidiary Xinxin (Hong Kong) Capital Co., Limited, and its other associates, holding an aggregate of 740,000,000 Shares representing approximately 15.91% of the total issued share capital of the Company as at the date of the EGM, were required to abstain from voting on the ordinary resolution numbered 1 to approve the Amendment JV Agreement and the Capital Increase Agreement.
As set out in the Circular and in accordance with the Listing Rules, each of Dr. Tzu-Yin Chiu and Dr. Haijun Zhao and their respective associates are required to abstain from voting on the relevant ordinary resolutions to approve the Proposed RSU Grants to Dr. Tzu-Yin Chiu and Dr. Haijun Zhao (as the case may be) and any transactions contemplated thereunder.
Dr. Tzu-Yin Chiu and his associates, holding an aggregate of 4,519,361 Shares representing approximately 0.097% of the total issued share capital of the Company as at the date of the EGM, were required to abstain from voting on the ordinary resolutions numbered 2 and numbered 4 to grant restricted share units to Dr. Tzu-Yin Chiu, the former Chief Executive Officer and a non-executive Director of the Company.
Dr. Haijun Zhao and his associates, holding an aggregate of 49,311 Shares representing 0.001 % of the total issued share capital of the Company as at the date of the EGM, were required to abstain from voting on the ordinary resolution numbered 3 to grant restricted share units to Dr. Haijun Zhao, the Chief Executive Officer of the Company.
The Company confirms that each of Xinxin (Hong Kong) Capital Co., Limited, other associates of China IC Fund, Dr. Tzu-Yin Chiu and Dr. Haijun Zhao and their respective associates has abstained from voting at the EGM pursuant to the aforesaid arrangements. There were no Shares entitling the holders to attend and vote only against any of the resolutions at the EGM.
The number of Shares represented by votes for and against the respective resolutions at the EGM was as follows:
4
|
|
|
|
|
|
|
|
|
ORDINARY RESOLUTIONS
|
No. of Votes (%)
|
For
|
Against
|
1
|
(a)
To receive, consider, approve, confirm and ratify the amended and restated joint venture agreement dated 10 August 2017 (the ‘‘Amendment JV Agreement’’) entered into between the Company, Semiconductor Manufacturing International (Beijing) Corporation, SMIC Holdings Corporation, China Integrated Circuit Industry Investment Fund Co., Ltd., Beijing Semiconductor Manufacturing and Equipment Equity Investment Center (Limited Partnership), Beijing Industrial Developing Investment Management Co., Ltd., Zhongguancun Development Group and E-Town Capital International Investment & Development Co., Ltd. in relation to further capital contributions towards Semiconductor Manufacturing North China (Beijing) Corporation, and the transactions contemplated thereby;
(b)
To receive, consider, approve, confirm and ratify the capital increase and subscription agreement dated 10 August 2017 (the ‘‘Capital Increase Agreement’’) entered into between the Company, Semiconductor Manufacturing International (Beijing) Corporation, SMIC Holdings Corporation, China Integrated Circuit Industry Investment Fund Co., Ltd.*, Beijing Semiconductor Manufacturing and Equipment Equity Investment Center (Limited Partnership), Beijing Industrial Developing Investment Management Co., Ltd., Zhongguancun Development Group, ETown Capital International Investment & Development Co., Ltd. and Semiconductor Manufacturing North China (Beijing) Corporation, and the transactions contemplated thereby; and
(c)
To authorise any director of the Company, for and on behalf of the Company, to enter into any agreement, deed or instrument and/or to execute and deliver all such documents and/or do all such acts on behalf of the Company as he/she may consider necessary, desirable or expedient for the purpose of, or in connection with (i) the implementations and completion of the Amendment JV Agreement, the Capital Increase Agreement and transactions contemplated thereunder; and/ or (ii) any amendment, variation or modification of the Amendment JV Agreement, the Capital Increase Agreement and the transactions contemplated thereunder upon such terms and conditions as the board of directors of the
Company may think fit.
|
1,617,696,726
99.9902%
|
158,200
0.0098%
|
As more than 50% of the votes were cast in favour of the resolution, the resolution was duly passed.
|
5
|
|
|
|
2
|
(a)
To
approve and confirm
the
proposed grant
of
1,054,659 restricted share
units
(‘‘RSUs’’) to Dr.
Tzu-Yin Chiu,
the
former Chief Executive Officer
of
the
Company,
in
accordance
with the
terms
of the 2014
Equity Incentive Plan,
and
subject
to
all applicable laws, rules, regulations
and the
other
applicable
documents;
and
(b)
To
authorise
any
director
of the
Company
to
exercise
the
powers
of the
Company
to
allot
and
issue
the
ordinary shares
of the
Company pursuant
to the
proposed
RSU
grant under
the
specific mandate granted
to
the
Directors
by
the
Shareholders
at the
annual general meeting
of the
Company held
on
13 June 2013
in
accordance
with the
terms
of the 2014
Equity Incentive Plan and/or
to
do
all
such acts
on
behalf
of the
Company
as
he/she
may
consider
necessary,
desirable
or
expedient
for the
purpose
of, or
in
connection with
the
implementation
and
completion
of the
transactions contemplated pursuant
to the proposed RSU grant.
|
2,141,504,595
90.6987%
|
219,614,443
9.3013%
|
As more than 50% of the votes were cast in favour of the resolution, the resolution was duly passed.
|
3
|
(a)
To
approve and confirm
the
proposed grant
of
1,687,500 restricted share
units
(‘‘RSUs’’) to Dr.
Haijun Zhao,
the
Chief Executive Officer
of the
Company,
in
accordance with
the
terms
of the
2014 Equity Incentive Plan,
and
subject
to
all applicable
laws,
rules,
regulations
and
the
other
applicable
documents;
and
(b)
To
authorise
any
director
of the
Company
to
exercise
the
powers
of the
Company
to
allot
and
issue
the
ordinary shares
of the
Company pursuant
to the
proposed
RSU
grant under
the
specific mandate granted
to
the
Directors
by
the
Shareholders
at the
annual general meeting
of the
Company held
on
13 June 2013
in
accordance
with the
terms
of the 2014
Equity Incentive Plan and/or
to
do
all
such acts
on
behalf
of the
Company
as
he/she
may
consider
necessary,
desirable
or
expedient
for the
purpose
of, or
in
connection with
the
implementation
and
completion
of the
transactions contemplated pursuant
to the proposed RSU grant.
|
2,141,564,785
90.7015%
|
219,549,238
9.2985%
|
As more than 50% of the votes were cast in favour of the resolution, the resolution was duly passed.
|
6
|
|
|
|
4
|
(a)
To
approve
and
confirm
the
proposed grant
of
187,500
restricted share
units
(‘‘RSUs’’) to Dr.
Tzu-Yin Chiu,
a
non-executive Director
of the
Company,
in
accordance with
the
terms
of the
2014 Equity Incentive Plan,
and
subject
to
all applicable
laws,
rules,
regulations
and
the
other
applicable
documents;
and
(b)
To
authorise
any
director
of the
Company
to
exercise
the
powers
of the
Company
to
allot
and
issue
the
ordinary shares
of the
Company pursuant
to the
proposed
RSU
grant under
the
specific mandate granted
to
the
Directors
by
the
Shareholders
at the
annual general meeting
of the
Company held
on
13 June 2013
in
accordance
with the
terms
of the 2014
Equity Incentive Plan and/or
to
do
all
such acts
on
behalf
of the
Company
as
he/she
may
consider
necessary,
desirable
or
expedient
for the
purpose
of, or
in
connection with
the
implementation
and
completion
of the
transactions contemplated pursuant
to the proposed RSU grant.
|
2,141,495,855
90.6985%
|
219,619,483
9.3015%
|
As more than 50% of the votes were cast in favour of the resolution, the resolution was duly passed.
|
The full text of Resolutions 1 to 4 above is set out in the Notice of Extraordinary General Meeting of the Company dated 13 September 2017.
Computershare Hong Kong Investor Services Limited, Hong Kong branch share registrar of the Company, acted as the scrutineer for the vote-taking at the EGM. The work performed by Computershare Hong Kong Investor Services Limited did not include provision of any assurance or advice on matters of legal interpretation or legal entitlement to vote.
By order of the Board
Semiconductor Manufacturing International Corporation
Gao Yonggang
Executive Director, Chief Financial Officer and Joint Company Secretary
Shanghai, PRC
29 September 2017
7
As at the date of this announcement, the directors of the Company are:
Executive Directors
Zhou Zixue (Chairman)
Gao Yonggang (Chief Financial Officer)
Non-executive Directors
Tzu-Yin Chiu (Vice Chairman)
Chen Shanzhi
Zhou Jie
Ren Kai
Lu Jun
Tong Guohua
Independent Non-executive Directors
Lip-Bu Tan
William Tudor Brown
Carmen I-Hua Chang
Shang-yi Chiang
Jason Jingsheng Cong
* For identification purposes only
8